Opioid Use in Patients With Inflammatory Bowel Disease.

Lin, Xiwu; Lofland, Jennifer; Zhang, Ling; Sloan, Sheldon; Chamaa, Laila; Marano, Colleen; Plevy, Scott.

Afiliação

Lin X; Quantitative Sciences, Janssen Pharmaceutical Research & Development, LLC., Spring House, Pennsylvania, USA.
Lofland J; Janssen Global Services, LLC., Horsham, Pennsylvania, USA.
Zhang L; Quantitative Sciences, Janssen Pharmaceutical Research & Development, LLC., Spring House, Pennsylvania, USA.
Sloan S; Janssen Global Services, LLC., Horsham, Pennsylvania, USA.
Chamaa L; Janssen Global Services, LLC., Horsham, Pennsylvania, USA.
Marano C; Immunology, Janssen Pharmaceutical Research & Development, LLC., Spring House, Pennsylvania, USA.
Plevy S; Immunology, Janssen Pharmaceutical Research & Development, LLC., Spring House, Pennsylvania, USA.

Crohns Colitis 360 ; 2(1): otaa009, 2020 Jan.

Article em En | MEDLINE | ID: mdl-36777960